Questions with the most recent answer or edit.
I have three data points across nine months, which I hope is enough to see a trend. This is presented as though it settles something, and I am not convinced it does.…
Stated plainly: orforglipron · 20 mg/mL · sixteen weeks. This is asserted often enough that I assumed it was established, and then I went looking for the source. I…
For reference: 4 mg · 3 mL · phosphate-buffered diluent · orforglipron. I am at the decision point and I would rather think it through than improvise. I would rather…
Numbers first: semaglutide · STEP 3. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
What I have: racemisation · 25 °C. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a boring answer. I would still…
The particulars: 99.1% · PeptideMeter · 98.8% · Medutest. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the arguments…
What I have: survodutide · method section. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single…
The specifics, since they change the answer: QYB · Chengdu · Canada. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan…
The method section is present, which is unusual enough that I want to make use of it. I would like help reading this properly rather than being told what conclusion…
I have the report as a PDF with the chromatogram on page two, so I can quote specifics. I am asking for verification rather than opinion, ideally with something I can…
What I am working with: creatinine · cagrilintide. I am trying to build something sustainable rather than something thorough that I will abandon. I have already…
What I am working with: tirzepatide · room temperature. I want a method I can write down and repeat, not a rule of thumb. I would rather over-engineer this than…
I have the full paper rather than the abstract, and the supplementary appendix. I have the document in front of me and I can read the numbers. What I cannot do is…
The specifics, since they change the answer: 25 °C · ecnoglutide. Somebody stated this to me confidently and I would like to check it before repeating it. I would…
I have continuous temperature data for the period in question, which is unusual and I would like to use it. I have a result I cannot explain, and I would rather…
Numbers first: mazdutide · sixteen weeks · minus 80 °C. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a boring…
Setup, so nobody has to ask: retatrutide · eight weeks · minus 80 °C. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real…
My eGFR is 92 and has been for years, which I had taken to mean my kidneys were not a topic. A urine albumin:creatinine ratio was added to a recent panel and came…
For reference: GL Biochem · Shanghai · the United States. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with…
The specifics, since they change the answer: fibrillation · survodutide · 2–8 °C. I understand the observation; what I do not understand is the mechanism behind it. I…
Setup, so nobody has to ask: 97.9% · sampling plan. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
Concretely: Suzhou · Canada. I would like help reading this properly rather than being told what conclusion to reach. I have the full report including the method…
For context, I am working with a 10 mg presentation and a 2 mL fill. I noticed this today and I have not touched anything since, in case the state is diagnostic. I…
Numbers first: a 1 mL luer-lock syringe · 2.5 mg · 4 mg/mL. I can do the algebra. I am not confident about the conversion factors. If there is a standard way to lay…